SCHEMBL5772378

SCHEMBL5772378

Cc1cccc2c1C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)CCCN2C(=O)OC(C)C

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.39
CCR2 P41597 18/20 0.39
KCNH2 Q12809 7/20 0.39
P2RX1 P51575 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3535678 0.91 CCR2 (0.41) TACR1CCR2KCNH2
SCHEMBL3534554 0.89 CCR2 (0.39) TACR1CCR2KCNH2
SCHEMBL3528790 0.87 TACR1 (0.43) TACR1CCR2
SCHEMBL2480202 0.83 CCR2 (0.42) TACR1CCR2KCNH2P2RX1
SCHEMBL2989300 0.83 CCR2 (0.40) TACR1CCR2
SCHEMBL3532857 0.83 CCR2 (0.42) TACR1CCR2KCNH2
SCHEMBL5635509 0.82 CCR2 (0.39) TACR1CCR2
SCHEMBL4768560 0.81 CETP (0.37) TACR1CCR2KCNH2
SCHEMBL13255065 0.81 CETP (0.52)
SCHEMBL2479621 0.80 CCR2 (0.37) TACR1CCR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670768-A1 COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA ELI LILLY AND COMPANY (US) 2006-06-21 EP disclosed
WO-2005037796-A1 COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA ELI LILLY AND COMPANY (US) 2005-04-28 WO disclosed